Blood-thinner treatment for complications of community pneumonia
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This Phase 3 trial tests whether an anti-clot “blood thinner” can reduce complications from community-acquired pneumonia in hospitalized adults who need extra oxygen. It may help by lowering harmful clot-related effects during serious lung infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You were admitted to the hospital for suspected or confirmed community pneumonia, and a chest X-ray shows a new or worsening lung change
- You have symptoms like cough or phlegm change, fever/low temperature, or abnormal white blood cell count
- You need supplemental oxygen (or more oxygen than usual if you already use it)
- The hospital expects you will stay at least 72 hours after being randomly assigned
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the antibiotic clarithromycin can prevent pneumonia from getting worse and turning into sepsis. It is for adults with community-acquired pneumonia who have certain signs of infection in their blood.
This trial compares how long antibiotics should be given to people hospitalized with moderately severe community-acquired pneumonia. It uses your early improvement to see which antibiotic duration works best and safely.
This trial tests an investigational medicine called Trimodulin (BT588) for people with severe pneumonia who need a breathing machine. The goal is to see if it helps them recover faster.
This Phase 2 trial tests whether using a blood test that shows clotting strength and “clot breakdown time” can help guide treatment for people in the ICU with acute respiratory failure from infection. If you qualify, the team will use these blood results to decide on clot-related therapy and compare outcomes to standard care.
This study tests personalized blood thinner treatments for people with blood clots in their lungs. It looks for patients who are older, have kidney problems, or have cancer, to see if adjusting the treatment helps them more.
This Phase 3 trial tests a catheter-based procedure to remove a lung blood clot (pulmonary embolism) and reduce strain on the heart. It may help people who have specific CT scan signs of right-heart strain.
Hear when a new Community-acquired Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.